< Back to Article

Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data

Table 1

Model inputs for disease progression and ivacaftor treatment efficacy [10, 13, 14, 35, 37–40].

doi: https://doi.org/10.1371/journal.pone.0283479.t001